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ABSTRACT
Elevated platelet-monocyte complexes (PMC) promote atherosclerosis and are associated with
cardiovascular disease. It is unknown whether consistent physical activity (PA) decreases circulating
PMCs. Additionally, no one has determined the monocyte phenotype most associated with PMCs.
PURPOSES: 1) to examine the influence of PA on PMCs and their association with inflammatory
/prothrombotic markers such as C-reactive protein (CRP), L-selectin (LS), platelet factor 4 (PF4), von
Willebrand Factor (vWF), and hemoglobin A1C (HbA1c) and 2) to determine the monocyte phenotype
most likely to form PMCs. METHODS: Thirty-one overweight/obese subjects (44±5yr, BMI 34.2±5 kgm2)
were divided into two groups: sedentary (SED, n=17) and physically active (PA, n=14) based on physical
activity logs. SED participated in < 1 h of formal exercise while PA participated in moderate-high
intensity exercise at least 3 h per week. Flow cytometry was used to identify PMCs on the monocyte
phenotypes: classical (CD14+CD16-), intermediate (CD14+CD16+), and non-classical (CD14+CD16++).
Platelets were identified using the marker CD42a. RESULTS: Percentage of circulating PMCs and median
fluorescence intensity of CD42a (MedFI; marker of platelet density per monocyte) were not different
between groups; however, monocyte phenotype significantly impacted PMC percentage and MedFI where
the lower the CD16 expression, the greater the adhesion of platelets. Classical monocytes (CD16-) had the
highest % of PMC, etc. (Fig 1). HbA1c was greater (p=0.031) and LS (p=0.019) was lower in SED compared
to PA (Fig. 2). There were no significant associations between any blood marker and PMC percentage, but
PF4 was correlated with percent of CD16 - (r= -0.482, p=0.031) and CD16+ (r= 0.473, p=0.035) monocytes.
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vWF (μg∙mL-1)
32 ± 3
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CONCLUSIONS: The absence of a separation between groups in VO2max may partially explain the lack of
a difference in PMCs between groups. Regarding our second aim, classical monocytes appear to be more
involved in PMC formation than do CD16+ monocytes with CD16++ having the lowest percentage of cells
with platelets adhered (PMC). This observation may be due to the shedding of adhesion molecules from
platelets and monocytes during activation from classical (CD16-) to a more inflammatory state (ie. CD16+).
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